Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Rapid Communications in Mass Spectrometry

• Publication date

  2003-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/RCM.919PMID 12569443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.

  2002cited by this paper
• Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives

  2002cited by this paper
• Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

  2002cited by this paper
• Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamphetamine and its metabolites in humans.

  2001cited by this paper
• Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans.

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001cited by this paper
• Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

  2000cited by this paper
• Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

  2000cited by this paper
• Pharmacology of MDMA in Humans

  2000cited by this paper
• (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

  2000cited by this paper
• Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.

  1999cited by this paper
• Chiral separations in capillary electrophoresis

  1999cited by this paper
• Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.

  1999cited by this paper
• Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.

  1999cited by this paper
• Death by "ecstasy": the serotonin syndrome?

  1998cited by this paper
• Separation of chiral compounds by capillary electrophoresis

  1998cited by this paper
• Enantioselective determination of 3,4‐methylene‐dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin‐modified capillary zone electrophoresis

  1997cited by this paper
• Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.

  1997cited by this paper
• Ecstasy and neurodegeneration

  1996cited by this paper
• Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)

  1996cited by this paper
• Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.

  1996cited by this paper
• A Fatal Trip with Ecstasy: A Case of 3,4-Methylene-Dioxymethamphetamine/ 3,4-Methylenedioxy-Amphetamine Toxicity

  1996cited by this paper
• Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.

  1996cited by this paper
• Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.

  1994cited by this paper
• MDMA (Ecstasy) Inhibition of MAO Type A and Type B: Comparisons with Fenfluramine and Fluoxetine (Prozac)

  1994cited by this paper
• The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

  1994cited by this paper
• Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry.

  1993cited by this paper
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

  1992cited by this paper
• 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.

  1991cited by this paper
• Detection of amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry following derivatization with (-)-menthyl chloroformate.

  1991cited by this paper
• Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.

  1990cited by this paper
• MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.

  1990cited by this paper
• Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine in the rat.

  1990cited by this paper
• Identification of metabolites of 3,4-(methylenedioxy)methamphetamine in human urine.

  1989cited by this paper
• Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood.

  1989cited by this paper
• Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.

  1986cited by this paper

• Enantioselective separation techniques in forensic analysis and clinical toxicology

  2024cites this paper
• MDMA to Treat PTSD in Adults.

  2021cites this paper
• Detection of l-Methamphetamine and l-Amphetamine as Selegiline Metabolites.

  2020cites this paper
• Interspecies In Vitro Evaluation of Stereoselective Protein Binding for 3,4-Methylenedioxymethamphetamine

  2017cites this paper
• The 2004 “ Research on Drug Evidence ” Report [ From the 14 th ICPO / INTERPOL Forensic Science Symposium ]

  2017cites this paper
• Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.

  2015cites this paper
• Mass Gathering Medicine at raves: Incidents and substance-related emergencies

  2013cites this paper
• Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.

  2012cites this paper
• Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.

  2012cites this paper
• Analytical Derivatization Techniques

  2012cites this paper
• Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology.

  2012cites this paper
• Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach.

  2011cites this paper
• Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.

  2011cites this paper
• Trends in bioanalytical methods for the determination and quantification of club drugs: 2000-2010.

  2011cites this paper
• Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.

  2010cites this paper
• Desenvolvimento de metodologia analítica para a investigação de anfetaminas em amostras de saliva, empregando cromatografia em fase gasosa acoplada a espectrometria de massas

  2010cites this paper
• Introductory Statement and General Investigational Plan This protocol is for a pilot study of 3,4-methylenedioxymethamphetamine (MDMA)- assisted therapy in people with treatment-resistant posttraumatic stress disorder (PTSD) arising from war or terrorism. This study is sponsored by the non-profit re

  2009influential citation
• Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Its Enantiomers in Mice: Pharmacokinetic Considerations

  2009influential citation
• High throughput chiral analysis of urinary amphetamines by GC-MS using a short narrow-bore capillary column

  2009cites this paper
• Ecstasy Analysis by Monolithic Materials-Capillary Electrochromatography

  2009cites this paper
• The role of Dopamine in the Sensitised Locomotor Activating Effects of Methylenedioxymethamphetamine (MDMA) in Rats

  2009cites this paper
• Fritless Xterra Particles Encapsulated Within a Poly(butylmethacrylate) Based Monolith for Use in CEC

  2009cites this paper
• MDMA-assisted Psychotherapy in people with Posttraumatic Stress Disorder

  2009cites this paper
• Development of a simultaneous liquid-liquid extraction and chiral derivatization method for stereospecific GC-MS analysis of amphetamine-type stimulants in human urine using fractional factorial design.

  2008influential citation
• A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain.

  2008cites this paper
• Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers.

  2008cites this paper
• Chapter 3 Amphetamines

  2008cites this paper
• Bioanalytical procedures for determination of drugs of abuse in blood

  2007cites this paper
• Time-resolved hair analysis of MDMA enantiomers by GC/MS-NCI.

  2007cites this paper
• MDMA-assisted Psychotherapy in Twelve People with War and Terrorism-related Posttraumatic Stress Disorder ( PTSD )

  2007influential citation
• (+/-)-3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") Investigator's Brochure

  2007cites this paper
• Simultaneous analysis of d-3-methoxy-17-methylmorphinan and l-3-methoxy-17-methylmorphinan by high pressure liquid chromatography equipped with PDA.

  2006cites this paper
• Sensitive, rapid and validated gas chromatography/negative ion chemical ionization-mass spectrometry assay including derivatisation with a novel chiral agent for the enantioselective quantification of amphetamine-type stimulants in hair.

  2006cites this paper
• High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology.

  2006cites this paper
• Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.

  2005cites this paper
• Derivatization in Mass Spectrometry—5. Specific Derivatization of Monofunctional Compounds

  2005cites this paper
• Proposed MAPS-Sponsored Israeli Pilot Study : MDMA-assisted Psychotherapy in Twelve People with War and Terrorism-related Posttraumatic Stress Disorder ( PTSD )

  2005influential citation
• Clinical pharmacokinetic data of racemic drugs obtained by the indirect method following precolumn diastereomer formation: is the influence of racemization during chiral derivatization significant?

  2004cites this paper
• Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).

  2004influential citation
• Evaluation of experimental strategies for the development of chiral chromatographic methods based on diastereomer formation.

  2004cites this paper
• Phase II dose-response pilot study of ±3,4-methylenedioxymethamphetamine (MDMA)- assisted psychotherapy in subjects with anxiety associated with advanced-stage cancer.

  2004influential citation
• Identification of some N-hydroxylated metabolites of (±)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry

  2003cites this paper
• Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.

  2003cites this paper
• Estudios controlados en humanos de éxtasis

  2003cites this paper
• Current literature in mass spectrometry.

  2003cites this paper
• Maps' Mdma Investigator's Brochure Update #1 a Review of Research in Humans and Non-human Animals

  2003influential citation
• Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Determination of the Designer Drugs MDA, MDMA (Ecstasy) and MDEA and Its Application to Samples From a Controlled Study with MDMA

  year unknowninfluential citation
• 2.1. SUMMARY OF THE PROPOSED STUDY...................................................................................... 3

  year unknowncites this paper